Receptors, IgG. CD 16 Antigens . CD 32 Antigens . CD 64 Antigens . CDw32 Antigens . Fc gamma RI . Fc gamma RII . Fc gamma RIII . Immunoglobulin G Receptor . Leu-11 Antigens . Antigens, CD 16 . Antigens, CD 32 . Antigens, CD 64 . Antigens, CDw32 . Antigens, Leu-11 . Leu 11 Antigens . Receptor, Immunoglobulin G . Receptors, gamma Fc . gamma RI, Fc . gamma RII, Fc . gamma RIII, Fc . gamma Receptors, Fc . gamma Fc Receptors . Antigens, CD16 . Antigens, CD32 . Antigens, CD64 . CD16 Antigens . CD32 Antigens . CD64 Antigens . Fc gamma Receptors . Fc Receptors, gamma . IgG Receptors . Receptors, Fc gamma . Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor). . 1.00
Receptors, IgE. CD 23 Antigens . CD23 Antigen . Fc epsilon RI . Fc epsilon RII . Immunoglobulin E Receptor . Antigen, CD23 . Antigens, CD 23 . Receptor, Immunoglobulin E . Receptors, epsilon Fc . epsilon RI, Fc . epsilon RII, Fc . epsilon Receptors, Fc . epsilon Fc Receptors . Antigens, CD23 . CD23 Antigens . Fc epsilon Receptors . Fc Receptors, epsilon . IgE Receptors . Receptors, Fc epsilon . Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI). . 0.58
Receptor, Insulin. Insulin Receptor alpha Chain . Insulin Receptor beta Chain . Insulin-Dependent Tyrosine Protein Kinase . Receptors, Insulin . Insulin Receptor Protein Tyrosine Kinase . Insulin Receptors . Insulin Receptor Protein-Tyrosine Kinase . Insulin Receptor . Insulin Receptor alpha Subunit . Insulin Receptor beta Subunit . INSULIN RECEPTORS . RECEPTORS, INSULIN . A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. . 0.56
Receptors, Interleukin-1. IL1 Receptors . Interleukin 1 Receptor . IL 1 Receptors . Interleukin 1 Receptors . Receptor, Interleukin 1 . Receptors, IL 1 . Receptors, IL1 . Receptors, Interleukin 1 . Interleukin-1 Receptors . IL-1 Receptors . Receptors, IL-1 . Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88. . 0.55
Receptor, ErbB-2. Antigens, CD340 . CD340 Antigen . Metastatic Lymph Node Gene 19 Protein . Neu Receptor . Oncogene Protein HER-2 . Proto-Oncogene Proteins c-erbB-2 . Proto-oncogene Protein Neu . Proto-oncogene c-ErbB-2 . Receptor, Neu . Receptors, erbB-2 . Tyrosine Kinase-type Cell Surface Receptor HER2 . p185(c-neu) . p185erbB2 Protein . CD340 Antigens . ErbB-2 Receptor . HER 2 Proto Oncogene Protein . Neu, Proto-oncogene Protein . Oncogene Protein HER 2 . Proto Oncogene Protein HER 2 . Proto Oncogene Proteins c erbB 2 . Proto-Oncogene Protein, HER-2 . Proto-Oncogene Protein, erbB-2 . Proto-Oncogene Protein, neu . Tyrosine Kinase type Cell Surface Receptor HER2 . c erbB 2 Protein . c-ErbB-2, Proto-oncogene . erbB 2 Proto Oncogene Protein . erbB 2 Receptor Protein Tyrosine Kinase . erbB-2 Receptors . neu Proto Oncogene Protein . c-erbB-2 Protein . erbB-2 Proto-Oncogene Protein . erbB-2 Receptor Protein-Tyrosine Kinase . neu Proto-Oncogene Protein . HER-2 Proto-Oncogene Protein . Proto-Oncogene Protein p185(neu) . Proto-Oncogene Protein HER-2 . neu Receptor . Receptor, neu . C-ERBB-2 PROTEINS . ERBB-2 PROTO-ONCOGENE PROTEINS . NEU PROTO-ONCOGENE PROTEINS . NEU RECEPTORS . P185(C-NEU) . HER-2 PROTO-ONCOGENE PROTEINS . PROTO-ONCOGENE PROTEINS HER-2 . RECEPTORS, NEU . PROTO-ONCOGENE PROTEINS C-ERBB-2 . A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member. . 0.54
Receptors, Interleukin-4. IL-4 Receptor . IL4 Receptor . IL4 Receptors . Interleukin 4 Receptor . IL 4 Receptor . IL 4 Receptors . Interleukin 4 Receptors . Receptor, IL-4 . Receptor, IL4 . Receptor, Interleukin 4 . Receptors, IL 4 . Receptors, IL4 . Receptors, Interleukin 4 . Interleukin-4 Receptors . IL-4 Receptors . Receptors, IL-4 . Receptors present on a wide variety of hematopoietic and non-hematopoietic cell types that are specific for INTERLEUKIN-4. They are involved in signaling a variety of immunological responses related to allergic INFLAMMATION including the differentiation of TH2 CELLS and the regulation of IMMUNOGLOBULIN E production. Two subtypes of receptors exist and are referred to as the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. Each receptor subtype is defined by its unique subunit composition. . 0.53